Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 38% ± 10% | |
lung | 16 studies | 42% ± 15% | |
intestine | 10 studies | 33% ± 15% | |
kidney | 7 studies | 36% ± 7% | |
liver | 7 studies | 35% ± 25% | |
eye | 6 studies | 25% ± 10% | |
brain | 6 studies | 27% ± 8% | |
lymph node | 5 studies | 35% ± 21% | |
placenta | 4 studies | 51% ± 22% | |
bone marrow | 4 studies | 32% ± 13% | |
breast | 4 studies | 29% ± 6% | |
pancreas | 3 studies | 43% ± 11% | |
uterus | 3 studies | 44% ± 19% | |
adrenal gland | 3 studies | 29% ± 5% | |
skin | 3 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2669.30 | 226 / 226 | 100% | 147.52 | 406 / 406 |
ovary | 100% | 1786.98 | 180 / 180 | 100% | 145.95 | 430 / 430 |
skin | 100% | 5742.83 | 1809 / 1809 | 100% | 260.61 | 472 / 472 |
uterus | 100% | 2084.85 | 170 / 170 | 100% | 277.64 | 459 / 459 |
esophagus | 100% | 3486.27 | 1444 / 1445 | 100% | 145.79 | 183 / 183 |
brain | 100% | 3483.46 | 2634 / 2642 | 100% | 143.67 | 705 / 705 |
thymus | 100% | 2333.05 | 652 / 653 | 100% | 121.47 | 604 / 605 |
stomach | 100% | 2365.52 | 359 / 359 | 100% | 157.82 | 285 / 286 |
kidney | 100% | 3264.13 | 89 / 89 | 100% | 110.96 | 897 / 901 |
intestine | 100% | 2963.97 | 966 / 966 | 99% | 178.85 | 524 / 527 |
prostate | 100% | 3248.14 | 245 / 245 | 99% | 228.09 | 498 / 502 |
adrenal gland | 100% | 4537.53 | 258 / 258 | 99% | 175.05 | 228 / 230 |
lung | 100% | 3347.35 | 576 / 578 | 99% | 166.51 | 1147 / 1155 |
breast | 100% | 3428.79 | 459 / 459 | 99% | 192.04 | 1106 / 1118 |
bladder | 100% | 2868.38 | 21 / 21 | 99% | 214.98 | 498 / 504 |
pancreas | 98% | 1457.18 | 323 / 328 | 99% | 169.48 | 177 / 178 |
adipose | 100% | 3813.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 190.12 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 273.17 | 29 / 29 |
spleen | 100% | 4275.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 249.78 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 163.99 | 1 / 1 |
peripheral blood | 100% | 3338.56 | 927 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3158.32 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 2066.26 | 793 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2267.73 | 836 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0098884 | Biological process | postsynaptic neurotransmitter receptor internalization |
GO_0048488 | Biological process | synaptic vesicle endocytosis |
GO_0006886 | Biological process | intracellular protein transport |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0048268 | Biological process | clathrin coat assembly |
GO_0030100 | Biological process | regulation of endocytosis |
GO_0072583 | Biological process | clathrin-dependent endocytosis |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0030122 | Cellular component | AP-2 adaptor complex |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
GO_0098794 | Cellular component | postsynapse |
GO_0005829 | Cellular component | cytosol |
GO_0045334 | Cellular component | clathrin-coated endocytic vesicle |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0036020 | Cellular component | endolysosome membrane |
GO_0035615 | Molecular function | clathrin adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AP2S1 |
Protein name | AP-2 complex subunit sigma (Clathrin assembly protein 2 sigma small chain) (Sigma2-adaptin) AP complex subunit sigma AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (HA2 17 kDa subunit) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin) |
Synonyms | CLAPS2 AP17 |
Description | FUNCTION: Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. The AP-2 alpha and AP-2 sigma subunits are thought to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif (By similarity). May also play a role in extracellular calcium homeostasis. . |
Accessions | ENST00000263270.11 [P53680-1] ENST00000601649.1 [P53680-2] ENST00000597020.5 ENST00000593442.5 ENST00000352203.8 X6R390 M0R0N4 M0QYZ2 M0QZ21 ENST00000599990.5 P53680 M0R1S0 ENST00000601498.5 |